人工智能在肝病学中应用的障碍及克服策略
本文评估了人工智能在肝病学临床实践与研究中的应用障碍,并通过涉及34名国际专家的德尔菲共识提出推荐意见,认为在临床试验中使用AI、无缝整合医院信息系统及提升临床医生AI素养将最终推动临床采纳。
要点
- AI在肝病学中的临床采纳仍有限,存在整合入常规工作流程的实质性障碍。
- 推荐通过德尔菲共识形成,涉及34名肝病学、AI与数据科学国际专家。
- 在临床试验中使用AI、无缝整合医院信息系统及提升临床医生AI素养被认为将驱动临床采纳。
核心结论
- AI在肝病学诊断、预后和预测工具向临床转化面临障碍,需从AI系统开发和肝病学环境两方面采取推荐措施。
研究设计与样本
- 立场论文,通过涉及34名肝病学、AI和数据科学国际专家的德尔菲共识验证观点。
临床应用与阅片要点
- 作者认为,在临床试验中使用AI、无缝整合医院信息系统及提升临床医生AI素养将最终驱动临床采纳。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Artificial intelligence (AI) methods in hepatology have proliferated since the mid-2010s, with numerous publications and some regulatory approvals. Yet, adoption of AI methods in real-world clinical practice and clinical research remains limited. Despite clear benefits of using AI to analyse complex data types in hepatology, such as histopathology, radiology images, multi-omics and more recently, natural language patient data, there are still substantial barriers and challenges to its integration into routine clinical workflows. In this position paper, we assess limitations and propose a set of clear recommendations aimed at both the development of AI systems and the broader hepatology environment to facilitate the transition of AI-based diagnostic, prognostic, and predictive tools into clinical care. In particular, we argue that the use of AI in clinical trials, seamless integration into hospital information systems and building AI literacy among clinicians will ultimately drive clinical adoption. We validate this perspective through a Delphi consensus involving 34 international experts from hepatology, AI, and data science, ensuring a comprehensive and consensus-driven evaluation of our recommendations.
引用
- Clusmann J, Balaguer-Montero M, Bassegoda O, et al. The barriers to uptake of artificial intelligence in hepatology and how to overcome them. J Hepatol. 2025. PMID: 40920593. doi:10.1016/j.jhep.2025.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。